Cancer Genetics (CGIX) – StreetInsider.com Reports
-
Cancer Genetics (CGIX) and StemoniX Announce Merger Closing
-
Cancer Genetics (CGIX) Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
-
Cancer Genetics (CGIX) Prices 2.78M Share Common Offering at $6.30/Sh
-
Cancer Genetics (CGIX) Announces $10 Million Private of Common Stock, Warrants
-
Cancer Genetics (CGIX) Announces $2M Bought Deal at $2.20/Share
-
Cancer Genetics (CGIX) and StemoniX Sign Definitive Agreement to Merge
-
Cancer Genetics (CGIX) Spikes Following Renaissance Tech 13G
-
Cancer Genetics (CGIX) Halted on LUDP
-
Cancer Genetics (CGIX) Climbs 220% After Earnings
-
Cancer Genetics (CGIX) Reports Q3 EPS of $0.98 (Earlier)
-
Cancer Genetics (CGIX) Announces 1-for-30 Reverse Stock Split
-
Interpace Diagnostics (IDXG) Acquires Cancer Genetics' (CGIX) Biopharma Services Business
-
Cancer Genetics (CGIX) Prices 15.217M Share Offering at $0.23/Sh
-
Cancer Genetics (CGIX) Announces Proposed Common Share Offering
-
Pre-Open Stock Movers 01/10: (DCIX) (VERI) (BBBY) Higher; (M) (MDB) (KSS) Lower (more...)
-
Cancer Genetics (CGIX) Prices 13.33M Share Common Offering at $0.225/Sh
-
After-Hours Movers 01/09: (DCIX) (VERI) (BBBY) Higher; (CGIX) (WDFC) (more...)
-
Cancer Genetics (CGIX) to Offer Common Stock
-
Cancer Genetics (CGIX) to Resume Trading at 8:30 am ET
-
Cancer Genetics (CGIX) Terminates Proposed Merger with NovellusDx
-
Cancer Genetics (CGIX) Halted, News Pending
-
Cancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial Officer
-
Cancer Genetics (CGIX) Announces Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China
-
Pre-Open Movers 09/26: (ALDX) (EGY) (GPRO) Higher; (NLST) (UPL) (NKE) Lower (more...)
-
After-Hours Stock Movers 09/25: (VSTM) (CGIX) (AIR) Higher; (DGLY) (ESNC) (NKE) Lower (more...)
-
Cancer Genetics (CGIX) Enters Supply Agreement with Agilent Technologies (A)
-
Cancer Genetics (CGIX) and NovellusDx Enter Definitive Agreement to Merge
-
Cancer Genetics (CGIX) Halted, News Pending
-
Cancer Genetics, Inc. (CGIX) PT Lowered to $3 at H.C. Wainwright
-
Cancer Genetics (CGIX) Reports Sale of India Operations to REPROCELL Inc. for $1.9M
-
Cancer Genetics' (CGIX) Tissue of Origin Test Receives Special FDA 510(k) Clearance
-
UPDATE: Dawson James Downgrades Cancer Genetics, Inc. (CGIX) to Neutral
-
Maxim Group Downgrades Cancer Genetics, Inc. (CGIX) to Hold
-
Cancer Genetics (CGIX) Announces CEO Panna Sharma to Step Down; Appoints John Roberts Interim
-
Cancer Genetics (CGIX) Secures Non-Dilutive Funding $1.1M from New Jersey Technology Business Tax Certificate Transfer Program
-
Cancer Genetics (CGIX) Announces New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific (TMO)
-
Cancer Genetics (CGIX) Prices $7M Registered Direct Offering of 3.5M Units
-
Maxim Group Starts Cancer Genetics, Inc. (CGIX) at Buy
-
Cancer Genetics (CGIX) Appoints Thomas Widmann to its Board of Directors
-
Cancer Genetics (CGIX) Announces Acquisition of vivoPharm for $12M
-
Cancer Genetics (CGIX) Misses Q2 EPS by 1c, Miss on Revenues
-
Pre-Open Movers 06/27: (CGIX) (ARNA) (DRI) Higher; (ALDR) (FNJN) (NEOS) Lower (more...)
-
Dawson James Starts Cancer Genetics, Inc. (CGIX) at Buy, "Acquisitions, New Products Fuel Emerging Leader"
-
Cancer Genetics (CGIX) Launches Companion Diagnostic for Lung Cancer Leveraging Thermo Fisher's Oncomine Dx Target Test
-
Benchmark Starts Cancer Genetics, Inc. (CGIX) at Speculative Buy
-
Cancer Genetics (CGIX) Shares Showing Weakness As StreetSweeper Issues Short Report
-
Cancer Genetics (CGIX) Partners with Roche's Ventana Medical Systems
-
Cancer Genetics (CGIX) Launches Multi-Gene Liquid Biopsy Test For Lung Cancer Patients
-
Cancer Genetics (CGIX) Confirms Partnership with Mendel Health Enabling Artificial Intelligence in Precision Medicine for Cancer Care
-
Cancer Genetics (CGIX) Tops Q4 EPS by 7c, Revenue Beats
Back to CGIX Stock Lookup